InvestSMART

HeraMED Limited (ASX:HMD)

ALERT: Price-sensitive ASX Announcement for HMD
Current share price for HMD : $0.038 0.002 (5.56%)+
Announcement
Release
27 Feb 2026 9:21AM
Price at Release
$0.036
Full Release
download
Summary
HeraMED Limited's Preliminary Final Report for the year ended 31 December 2025 showed a 10.3% decrease in revenues from ordinary activities, amounting to $431,605. The loss from ordinary activities after tax attributable to the owners decreased by 24.8% to $4,131,627, with no dividends declared for the period. Net tangible assets per ordinary security fell to 0.11 cents from 0.23 cents in the previous year. The financial statements were audited with an unmodified opinion, and all entities applied Australian Accounting Standards.
Key Points
  • Revenues from ordinary activities decreased by 10.3% to $431,605.
  • The loss from ordinary activities after tax attributable to the owners decreased by 24.8% to $4,131,627.
  • No dividends were paid, recommended, or declared during the current financial period.
  • Net tangible assets per ordinary security decreased to 0.11 cents from 0.23 cents in the previous period.
  • The financial statements were audited and an unmodified opinion was issued.
  • The report includes results for the year ended 31 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.